These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38275516)

  • 1. Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease.
    Muraleedharan A; Ray SK
    Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
    Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
    J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
    Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
    J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate-derived carbonized polymer dots: A multifunctional scavenger targeting Alzheimer's β-amyloid plaques.
    Lin X; Liu W; Dong X; Sun Y
    Acta Biomater; 2023 Feb; 157():524-537. PubMed ID: 36503076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.
    Zhu F; Li C; Chu F; Tian X; Zhu J
    Front Aging Neurosci; 2020; 12():544235. PubMed ID: 33132894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer's Disease via Gut Microbiome.
    Torraville SE; Flynn CM; Kendall TL; Yuan Q
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Immunotherapy for Alzheimer's Disease.
    Dai CL; Liu F; Iqbal K; Gong CX
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions.
    Nafady MH; Sayed ZS; Abdelkawy DA; Shebl ME; Elsayed RA; Ashraf GM; Perveen A; Attia MS; Bahbah EI
    Curr Alzheimer Res; 2022; 19(4):274-284. PubMed ID: 35440296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
    Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease.
    Narengaowa ; Kong W; Lan F; Awan UF; Qing H; Ni J
    Front Cell Neurosci; 2021; 15():633735. PubMed ID: 33935651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
    Qian XH; Liu XL; Chen G; Chen SD; Tang HD
    J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration.
    Solanki R; Karande A; Ranganathan P
    Front Neurol; 2023; 14():1149618. PubMed ID: 37255721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease.
    Borsom EM; Lee K; Cope EK
    Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33153085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.